Login / Signup

Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland.

H O'NeillI NarangD A BuckleyT A PhillipsC G BertramT O BleikerM M U ChowdhuryS M CooperS Abdul GhaffarG A JohnstonLisa KielyJ E SansomN StoneD A ThompsonP Banerjee
Published in: The British journal of dermatology (2020)
During the Covid-19 pandemic, with the increased need for donning personal protective equipment (PPE) and frequent handwashing, we have noted growing reports from at home and abroad of high rates of irritant dermatitis in frontline healthcare workers (HCWs). In China, where the SARS Cov-2 virus was first reported, up to 97% of frontline HCWs reported skin changes related to new infection control practices.1,2 A recent study of 146 HCWs from Manchester and London diagnosed irritant contact dermatitis (ICD) in 97.1%, with high rates of pressure-related facial dermatitis from masks and goggles.
Keyphrases
  • sars cov
  • primary care
  • healthcare
  • soft tissue
  • cross sectional
  • clinical trial
  • atopic dermatitis
  • randomized controlled trial
  • study protocol
  • respiratory syndrome coronavirus
  • adverse drug
  • drug induced